New implications for prion diseases therapy and prophylaxis

Area of Science:

• Neuroscience
• Pathology
• Pharmacology

Background:

• Prion diseases are rare, fatal, progressive neurodegenerative disorders affecting humans and animals, with Creutzfeldt-Jakob disease (CJD) being the most common human form.
• Current therapeutic options for prion diseases are limited, with significant challenges including toxicity, poor efficacy, and inadequate pharmacokinetics of existing compounds.
• The discovery of pathogenic misfolding prion protein (PrPSc) has spurred research into novel strategies to eliminate it.

Purpose of the Study:

• To review emerging therapeutic and prophylactic strategies for prion diseases.
• To explore novel approaches including immunotherapy, gene therapy, small-molecule drugs, and stem cell therapy.
• To discuss the prospects and challenges of these innovative treatments for prion diseases.

Main Methods:

• Literature review of experimental and clinical research on prion diseases.
• Analysis of novel technologies aimed at eliminating pathogenic misfolding prion protein (PrPSc).
• Evaluation of emerging therapeutic approaches such as immunotherapy, gene therapy, small-molecule drugs, and stem cell therapy.

Main Results:

• Numerous chemical compounds have shown experimental efficacy but face limitations in toxicity, efficacy, and pharmacokinetics.
• Early CJD treatments using anti-infective agents provided minimal clinical benefit.
• Novel technologies are being developed to target and eliminate PrPSc, offering potential therapeutic avenues.

Conclusions:

• Emerging therapeutic approaches like immunotherapy, gene therapy, small-molecule drugs, and stem cell therapy show promise for prion diseases.
• Significant challenges remain in translating experimental findings into effective clinical treatments.
• Continued research is crucial to overcome limitations and develop viable therapies for these devastating neurodegenerative conditions.